The therapeutic window of opportunity in rheumatoid arthritis: Does it ever close?

Annals of the Rheumatic Diseases

Volumn 74, Issue 5, 2015, Pages 793-794

  Raza, Karim ^a,b   Filer, Andrew ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ARTHRALGIA; DELAYED DIAGNOSIS; DISEASE DURATION; EARLY INTERVENTION; EDITORIAL; FATIGUE; HELP SEEKING BEHAVIOR; HUMAN; JOINT SWELLING; PATIENT ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS; THERAPY DELAY; TREATMENT OUTCOME; ARTHRITIS, RHEUMATOID; FEMALE; MALE; TIME TO TREATMENT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; TIME-TO-TREATMENT;

EID: 84926661159     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206993     Document Type: Editorial

References (24)

1. Nell VP, Machold KP, Eberl G, et al Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004; 43:906-14.
2. van der Linden MP, le Cessie S, Raza K, et al Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum 2010; 62:3537-46.
3. Kyburz D, Gabay C, Michel B.A., et al. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology (Oxford) 2011; 50:1106-10.
4. Finckh A, Liang MH, van Herckenrode CM, et al. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006; 55:864-72.
5. Landewe RB, Boers M, Verhoeven A.C., et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46:347-56.
6. van Nies J.A., Tsonaka R, Gaujoux-Viala C, et al. Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts. Ann Rheum Dis 2015; 74:806-12.
7. Raza K, Stack R, Kumar K., et al. Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 2011; 70:1822-5.
8. Villeneuve E, Nam JL, Bell M.J., et al. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Ann Rheum Dis 2013; 72:13-22.
9. Kumar K, Daley E, Carruthers D.M., et al. Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) 2007; 46:1438-40.
10. De Cock D., Meyfroidt S, Joly J., et al. A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients. Scand J Rheumatol 2014; 43:1-8.
11. Stack RJ, Shaw K, Mallen C., et al. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann Rheum Dis 2012; 71:493-7.
12. van Nies J.A., Brouwer E, van Gaalen FA, et al. Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics. Ann Rheum Dis 2013; 72:1295-301.
13. Raza K. The Michael Mason prize: early rheumatoid arthritis - the window narrows. Rheumatology (Oxford) 2010; 49:406-10.
14. Raza K, Falciani F, Curnow S.J., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005; 7:R784-95.
15. Raza K, Saber TP, Kvien T.K., et al. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials. Ann Rheum Dis 2012; 71:1921-3.
16. Stack RJ, Sahni M, Mallen C.D., et al. Symptom complexes at the earliest phases of rheumatoid arthritis: a synthesis of the qualitative literature. Arthritis Care Res (Hoboken) 2013; 65:1916-26.
17. Stack RJ, van Tuyl LH, Sloots M, et al. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development. Rheumatology (Oxford) 2014; 53:1646-53.
18. Gerlag DM, Raza K, van Baarsen LG, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012; 71:638-41.
19. van de Stadt LA, Witte BI, Bos W.H., et al. A prediction rule for the development of arthritis in seropositive arthralgia patients. Ann Rheum Dis 2013; 72:1920-6.
20. van de Stadt LA, Bos WH, Meursinge Reynders M, et al. The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study. Arthritis Res Ther 2010; 12:R98.
21. Rakieh C, Nam JL, Hunt L, et al Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis 2014. Published Online First: 12 Apr 2014. doi:10.1136/annrheumdis-2014-205227
22. Filer A, de Pablo P, Allen G, et al Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis. Ann Rheum Dis 2011; 70:500-7.
23. Stomp W, Krabben A, van der Heijde D, et al. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5 T extremity magnetic resonance imaging? A large cross-sectional study. J Rheumatol 2014; 41:1630-7.
24. Krabben A, Stomp W, van Nies JA, et al. MRI-detected subclinical joint inflammation is associated with radiographic progression. Ann Rheum Dis 2014; 73:2034-7.